Al Hammadi Holding vs Dallah Healthcare Co.
A head-to-head of Al Hammadi Holding (4007) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4007 | 4004 |
|---|---|---|
| Market Cap | 4.23B SAR | 10.78B SAR |
| P/E (TTM) | 17.81 | 20.02 |
| Forward P/E | 12.48 | 20.80 |
| P/S | 3.38 | 2.67 |
| P/B | 2.12 | 2.64 |
| EV/EBITDA | 14.00 | 20.79 |
| Dividend Yield | 3.02% | 1.79% |
| Profit Margin | 17.91% | 11.15% |
| Gross Margin | 29.41% | 35.71% |
| Operating Margin | 19.21% | 15.40% |
| Revenue Growth (YoY) | +5.70% | +21.68% |
| FCF Yield | -1.50% | -0.21% |
| Debt / Equity | 8.25 | 94.09 |
| Current Ratio | 2.35 | 1.20 |
Which is better: Al Hammadi Holding or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Al Hammadi Holding
- ✓Higher dividend yield: Al Hammadi Holding
- ✓More profitable (net margin): Al Hammadi Holding
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Dallah Healthcare Co.
Across 13 available metrics, Al Hammadi Holding leads 9–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Al Hammadi Holding with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.